Kilitch Drugs Reports Quarterly Results for Q2 FY26; Standalone and Consolidated Performance Details
Kilitch Drugs (India) Limited released its Unaudited Financial Results for the quarter ending June 30, 2026. The company reported key financial metrics across both standalone and consolidated segments, detailing performance against previous periods.Standalone Financial Highlights
For the quarter ended June 30, 2026, Kilitch Drugs recorded a Total Income of 4,445.96 Lakhs. Net Sales from operations stood at 4,091.20 Lakhs, complemented by Other Income of 354.76 Lakhs.Total Expenses for the quarter amounted to 3,751.16 Lakhs, including Cost of Materials Consumed (2,024.54 Lakhs), Employee Benefit Expenses (352.50 Lakhs), and Other...